3D Bioprinted Human Tissue Market Report 2026

3D Bioprinted Human Tissue Market Overview

• 3D Bioprinted Human Tissue market size has reached to $1.93 billion in 2025 • Expected to grow to $3.59 billion in 2030 at a compound annual growth rate (CAGR) of 13.2% • Growth Driver: Increasing Demand For Organ Transplants Is Fueling The Growth Of The Market Due To The Need For Life-Saving, Patient-Specific Tissue Solutions • Market Trend: Technological Innovations In Patient-Derived Sample Optimization Driving Advances In 3D Tissue Modeling And Drug Discovery • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under 3D Bioprinted Human Tissue Market?

3D bioprinted human tissue is a three-dimensional structure created by using bioprinting technology that deposits living cells, bioinks, and biomaterials layer-by-layer to fabricate tissue. The purpose of 3D bioprinted human tissue is to produce functional tissue models for applications such as regenerative medicine, drug testing, disease modeling, and potentially organ transplantation. The main types of 3D bioprinted human tissues include skin, cartilage, liver, bone, heart, and others. Skin tissue refers to bioprinted layers that replicate the protective outer covering of the body, useful for wound healing and grafting. It uses various technologies such as extrusion-based, inkjet bioprinting, laser-assisted bioprinting, microfluidic and acoustic, magnetic levitation, and hybrid or 4D and various materials, including natural biomaterials, synthetic biomaterials, decellularized extracellular matrices, hydrogels, composite materials, and others. It is applied for tissue engineering, cosmetic surgery, drug testing and development, and food testing by several end-users, including pharmaceutical companies, biotechnology firms, academic research institutions, contract research organizations, and hospitals and clinics.

What Is The 3D Bioprinted Human Tissue Market Growth Forecast?

The 3d bioprinted human tissue market size is expected to see rapid growth in the next few years. It will grow to $3.59 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to advancements in bioprinting resolution and scalability, increasing investment in regenerative medicine, growing pharmaceutical demand for predictive drug testing models, expansion of organ transplantation research, supportive regulatory frameworks for advanced therapies. Major trends in the forecast period include increasing use of 3d bioprinted tissues in drug testing and disease modeling, rising demand for regenerative medicine and tissue engineering solutions, growth in customized and patient-specific tissue constructs, expansion of academic and clinical research collaborations, increasing adoption of bioprinted tissues as alternatives to animal testing.

What Is The Driver Of The 3D Bioprinted Human Tissue Market?

The increasing demand for organ transplants is expected to propel the growth of the 3D bioprinted human tissue market going forward. Organ transplantation refers to the medical procedure of transferring organs from a donor to a recipient to replace damaged or failing organs. The growing demand for organ transplants is due to patients seeking life-saving procedures that reduce waiting times, improve survival rates, and offer hope through accessible and reliable transplant solutions. 3D bioprinted human tissue offers a transformative solution for organ transplants by enabling the creation of patient-specific, functional tissues that reduce rejection risk and lessen dependence on donor organs. For instance, in January 2025, according to the Organ Procurement and Transplantation Network, a US-based non-profit organization, there was a modest rise in kidney transplants, reaching 27,759 in 2024, an increase of 1.6 percent compared to 2023. In contrast, the number of heart transplants remained nearly the same, with 4,572 procedures in 2024 compared to 4,545 in 2023. Therefore, the increasing demand for organ transplants is driving the growth of the 3D bioprinted human tissue industry.

Key Players In The Global 3D Bioprinted Human Tissue Market

Major companies operating in the 3d bioprinted human tissue market are Inventia Life Science PTY LTD., Aspect Biosystems Ltd., Cellink Global AB, Prellis Biologics Inc., Cyfuse Biomedical K.K., Poietis SAS, Fluidform LLC, EpiBone Inc., Carcinotech Ltd., Organovo Holdings Inc., CollPlant Biotechnologies Ltd.

Global 3D Bioprinted Human Tissue Market Trends and Insights

Major companies operating in the 3D bioprinted human tissue market are focusing on developing innovative approaches, such as patient-derived sample optimization, to create highly accurate and personalized tissue models that improve drug testing, disease research, and regenerative medicine outcomes. Patient-derived sample optimization is the enhanced ability to efficiently use limited patient cells to create multiple high-quality, biologically relevant 3D tissue models for more accurate and personalized research outcomes. For instance, in January 2025, Inventia Life Science Pty Ltd., an Australia-based biotechnology company, launched the RASTRUM solution as part of its Inventia Life Science suite, specifically designed to enhance the rapid, precise, and reproducible creation of complex 3D human tissue models that closely mimic real human tissues for use in drug discovery, disease modeling, and regenerative medicine. It uses advanced drop-on-demand bioprinting technology to automate and scale the production of 3D cell cultures in standard lab plate formats, significantly reducing manual effort and variability. This allows researchers to conduct high-throughput, consistent experiments with biologically relevant tissue models, helping to accelerate discoveries and improve the predictability of preclinical research outcomes.

What Are Latest Mergers And Acquisitions In The 3D Bioprinted Human Tissue Market?

In October 2023, Carcinotech Ltd, a UK-based company specialising in 3D-printed micro-tumour models for oncology drug screening, partnered with CELLINK AB to develop and commercialise protocols for the bio-fabrication of 3D bioprinted tumour models based on cancer cell lines. With this partnership, Carcinotech and CELLINK aim to combine Carcinotech’s expertise in tumour modelling with CELLINK’s automated BIO CELLX system to accelerate oncology research workflows, improve reproducibility and reduce development costs. CELLINK AB is a Sweden-based bioconvergence company delivering bioprinting systems, bioinks and automated laboratory solutions.

What Defines the 3D Bioprinted Human Tissue Market?

The 3D bioprinted human tissue market consists of revenues earned by entities by providing services such as commercial manufacturing of bioprinted tissues, drug testing and development, and research and development services. The market value includes the value of related goods sold by the service provider or included within the service offering. The 3D bioprinted human tissue market also includes sales of bioinks, tissue constructs for transplantation, synthetic and natural polymers, hydrogels, and scaffold materials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the 3D Bioprinted Human Tissue Market Report 2026?

The 3d bioprinted human tissue market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the 3d bioprinted human tissue industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.